| protein kinase C, theta |
BIS(2-ETHYLHEXYL)PHTHALATE |
Phorbol Ester |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, iota |
BIS(2-ETHYLHEXYL)PHTHALATE |
Phorbol Ester |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, epsilon |
BIS(2-ETHYLHEXYL)PHTHALATE |
Phorbol Ester |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, zeta |
BIS(2-ETHYLHEXYL)PHTHALATE |
Phorbol Ester |
-18% |
NoneNone |
NoneNone |
View
|
| protein kinase C, gamma |
BIS(2-ETHYLHEXYL)PHTHALATE |
Phorbol Ester |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 4 |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 8 |
TROMETHAMINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3a |
BISPHENOL A |
Serotonin 5-HT3 |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 3b |
BISPHENOL A |
Serotonin 5-HT3 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
AMOXICILLIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
AMOXICILLIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
AMOXICILLIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
AMOXICILLIN |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
BUPROPION |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
BUPROPION |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor |
BUPROPION |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| leukotriene B4 receptor 2 |
BUPROPION |
Leukotriene B4 |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
THIOACETAMIDE |
Glutamate, NMDA, Agonism |
-18% |
NoneNone |
NoneNone |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
FELBINAC |
CYP450-2C9 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
FELBINAC |
CYP450-2C9 Inhibition |
-18% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 2 |
SULOCTIDIL |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
SULOCTIDIL |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| natriuretic peptide receptor 3 |
SULOCTIDIL |
Atrial Natriuretic Factor (ANF) |
-18% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DIDANOSINE |
Adrenergic, Norepinephrine Transporter |
-18% |
NoneNone |
NoneNone |
View
|
| FMS-like tyrosine kinase 1 |
DOMPERIDONE |
Vascular Endothelinal Growth Factor (VEGF) |
-18% |
NoneNone |
NoneNone |
View
|
| fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
DOMPERIDONE |
Vascular Endothelinal Growth Factor (VEGF) |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
SULFAMERAZINE |
Serotonin 5-HT4 |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
SULFAMERAZINE |
Serotonin 5-HT4 |
-18% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
CHOLINE ALFOSCERATE |
Serotonin 5-HT2B |
-18% |
NoneNone |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
THIOCTIC ACID |
Protein Tyrosine Kinase, Fyn |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 3 |
RILUZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 3 |
RILUZOLE |
Protein Serine/Threonine Kinase, ERK1 |
-18% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, beta polypeptide |
FELBINAC |
Platelet-Derived Growth Factor (PDGF) |
-18% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, alpha polypeptide |
FELBINAC |
Platelet-Derived Growth Factor (PDGF) |
-18% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, alpha polypeptide |
FELBINAC |
Platelet-Derived Growth Factor (PDGF) |
-18% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, beta polypeptide |
FELBINAC |
Platelet-Derived Growth Factor (PDGF) |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
ERGOCALCIFEROL |
Phosphodiesterase PDE5 |
-18% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 5A, cGMP-specific |
ERGOCALCIFEROL |
Phosphodiesterase PDE5 |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, epsilon polypeptide |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 4 |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 5 |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
TOLPERISONE |
Nicotinic Acetylcholine, Central |
-18% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 5 |
ALFACALCIDOL |
Muscarinic M5 |
-18% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
CHROMIUM(III) CHLORIDE |
HMG-CoA Reductase |
-18% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
CHROMIUM(III) CHLORIDE |
HMG-CoA Reductase |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, NMDA2C |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
KANAMYCIN |
Glutamate, NMDA, Phencyclidine |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA1 (alpha 1) |
THIORIDAZINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA2 |
THIORIDAZINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, AMPA3 (alpha 3) |
THIORIDAZINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| glutamate receptor subunit 4c |
THIORIDAZINE |
Glutamate, AMPA |
-18% |
NoneNone |
NoneNone |
View
|
| nuclear receptor subfamily 3, group C, member 1 |
EUGENOL |
Glucocorticoid |
-18% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D1A |
FLUNOXAPROFEN |
Dopamine D1 |
-18% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
PANTOPRAZOLE |
Calcium Channel Type L, Benzothiazepine |
-16% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CHLORDIAZEPOXIDE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
CHLORDIAZEPOXIDE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
| ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CHLORDIAZEPOXIDE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha polypeptide |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 gamma |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
PROGLUMIDE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
GADOPENTETATE DIMEGLUMINE |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
GADOPENTETATE DIMEGLUMINE |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
MADURAMICIN |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
CLORPRENALINE |
Endothelin ETA |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 |
SELEGILINE |
Adenosine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| concentrative Na+ nucleoside cotransporter (DBSS) |
SELEGILINE |
Adenosine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 |
SELEGILINE |
Adenosine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| adenine nucleotide translocase (DBSS) (Non-specific probe) |
SELEGILINE |
Adenosine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 |
SELEGILINE |
Adenosine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 1 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, pi |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| AT hook, DNA binding motif, containing 1 (DBSS) |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, theta |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, gamma 2 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 2 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, alpha 1 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid A receptor, delta |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
NORFLOXACIN |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
| dopamine receptor D4 |
RITONAVIR |
Dopamine D4.2 |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
NADOLOL |
Serotonin 5-HT1B |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
RITONAVIR |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
RITONAVIR |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| tachykinin receptor 1 |
NIMODIPINE |
Tachykinin NK1 |
-16% |
NoneNone |
NoneNone |
View
|
| chemokine (C-C motif) receptor 5 |
NITROFURANTOIN |
Chemokine CCR5 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
OLANZAPINE |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
OLANZAPINE |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
MEXILETINE |
Estrogen ERalpha |
-16% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 3 |
1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 1 subunit |
1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
| glycine receptor, beta subunit |
1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
| glycine receptor, alpha 2 subunit |
1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LETROZOLE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
LETROZOLE |
HMG-CoA Reductase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
1-NAPHTHYL ISOTHIOCYANATE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
1-NAPHTHYL ISOTHIOCYANATE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
METHOCARBAMOL |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
| cysteinyl leukotriene receptor 1 |
METHOCARBAMOL |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 1 |
MITOTANE |
Histamine H1, Central |
-16% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, beta |
MITOTANE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
| cannabinoid receptor 1 (brain) |
DIELDRIN |
Cannabinoid CB1 |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 5 (DBSS) |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1b |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| tumor necrosis factor receptor superfamily, member 1a |
MITOTANE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, epsilon polypeptide |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 4 |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 5 |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
CROTAMITON |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
CROTAMITON |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
| platelet-activating factor receptor |
D-CAMPHOR |
Platelet Activating Factor (PAF) |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 4 |
FLUORESCEIN |
Muscarinic M4 |
-16% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
CAPSAICIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
| monoamine oxidase A |
CAPSAICIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, alpha |
CAFFEIC ACID PHENETHYL ESTER |
Chemokine CXCR1(IL-8A) |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
DEXTROMETHORPHAN |
Serotonin 5-HT1B |
-16% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 1 |
DIAZOXIDE |
Muscarinic M1 |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
FLUOXETINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
FLUOXETINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 5B |
S(-)-CARBIDOPA |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 4 |
S(-)-CARBIDOPA |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
S(-)-CARBIDOPA |
Imidazoline I2, Central |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
BENAZEPRIL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|